Verus Financial Partners, Inc. Abb Vie Inc. Transaction History

Verus Financial Partners, Inc.

$852 Million
Q1 2024

A detailed history of Verus Financial Partners, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Verus Financial Partners, Inc. holds 3,675 shares of ABBV stock, worth $617,583. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,675

Previous 3,670 0.14%

Holding current value

$617,583

Previous $568,000 17.78%

% of portfolio

0.08%

Previous 0.07%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$159.82 - $182.1 $799 - $910	5 Added 0.14%	3,675 $669,000
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $51,324 - $57,803	373 Added 11.31%	3,670 $568,000
Q3 2023 Oct 23, 2023	BUY	$133.59 - $154.65 $80,821 - $93,563	605 Added 22.47%	3,297 $491,000
Q2 2023 Jul 27, 2023	SELL	$132.51 - $164.9 $98,719 - $122,850	-745 Reduced 21.68%	2,692 $362,000
Q1 2023 May 05, 2023	SELL	$144.61 - $166.54 $19,811 - $22,815	-137 Reduced 3.83%	3,437 $547,000

Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $8,713 - $10,449	-63 Reduced 1.73%	3,574 $577,000
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $110,991 - $127,300	827 Added 29.43%	3,637 $526,000
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $688 - $874	5 Added 0.18%	2,810 $415,000
Q1 2022 Apr 15, 2022	SELL	$131.98 - $163.75 $69,289 - $85,968	-525 Reduced 15.77%	2,805 $469,000
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $107 - $135	1 Added 0.03%	3,330 $451,000
Q3 2021 Oct 29, 2021	SELL	$106.4 - $120.78 $51,178 - $58,095	-481 Reduced 12.62%	3,329 $358,000
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $23,040 - $25,668	219 Added 6.1%	3,810 $442,000
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $51,047 - $56,197	-499 Reduced 12.2%	3,591 $378,000
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $329,204 - $444,460	4,090 New	4,090 $438,000
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $277,059 - $325,176	-3,225 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$73.37 - $98.18 $15,187 - $20,323	-207 Reduced 6.03%	3,225 $317,000
Q1 2020 Apr 09, 2020	BUY	$64.5 - $97.79 $11,545 - $17,504	179 Added 5.5%	3,432 $261,000
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $793 - $992	11 Added 0.34%	3,253 $288,000
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $28,718 - $34,528	456 Added 16.37%	3,242 $245,000
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $10,117 - $12,932	154 Added 5.85%	2,786 $203,000
Q1 2019 Apr 19, 2019	BUY	$77.14 - $90.79 $617 - $726	8 Added 0.3%	2,632 $212,000
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $266 - $296	3 Added 0.11%	2,624 $248,000
Q2 2018 Jul 16, 2018	BUY	$89.78 - $106.23 $269 - $318	3 Added 0.11%	2,621 $243,000
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $3,404 - $4,558	-37 Reduced 1.39%	2,618 $248,000
Q4 2017 Jan 29, 2018	SELL	$89.56 - $98.21 $2,865 - $3,142	-32 Reduced 1.19%	2,655 $257,000
Q3 2017 Nov 03, 2017	BUY	$69.85 - $89.22 $187,686 - $239,734	2,687	2,687 $239,000

Others Institutions Holding ABBV

# of Institutions

3,657

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Verus Financial Partners, Inc. with notifications on news.

Account

Verus Financial Partners, Inc. Abb Vie Inc. Transaction History